Does TISLELIZUMAB Cause Hepatic function abnormal? 221 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 221 reports of Hepatic function abnormal have been filed in association with TISLELIZUMAB (TEVIMBRA). This represents 4.4% of all adverse event reports for TISLELIZUMAB.
221
Reports of Hepatic function abnormal with TISLELIZUMAB
4.4%
of all TISLELIZUMAB reports
1
Deaths
144
Hospitalizations
How Dangerous Is Hepatic function abnormal From TISLELIZUMAB?
Of the 221 reports, 1 (0.5%) resulted in death, 144 (65.2%) required hospitalization, and 3 (1.4%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISLELIZUMAB. However, 221 reports have been filed with the FAERS database.
What Other Side Effects Does TISLELIZUMAB Cause?
Myelosuppression (2,142)
White blood cell count decreased (327)
Neutrophil count decreased (277)
Pruritus (213)
Rash (208)
Platelet count decreased (183)
Pyrexia (175)
Nausea (165)
Diarrhoea (145)
Liver injury (139)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which TISLELIZUMAB Alternatives Have Lower Hepatic function abnormal Risk?
TISLELIZUMAB vs TISOTUMAB VEDOTIN
TISLELIZUMAB vs TISOTUMAB VEDOTIN-TFTV
TISLELIZUMAB vs TITANIUM DIOXIDE\ZINC
TISLELIZUMAB vs TIVICAY
TISLELIZUMAB vs TIVOZANIB